Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis
Objective To evaluate the safety profiles of EZH2-targeted inhibitors in cancer treatment, focusing on treatment-related adverse events (TRAEs) across various clinical trials. Methods We conducted a systematic review and meta-analysis using data from clinical trials involving EZH2 inhibitors reporte...
Saved in:
Main Authors: | Zhou Zhao, Xiufeng Chen, Huayang Pang, Yan Shi, Hao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2025-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/18871.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials
by: Mitra Hariri, et al.
Published: (2025-02-01) -
Clinical efficacy and safety of proton radiotherapy for ocular conjunctival malignancies: a systematic review and meta-analysis
by: Tingwei Zheng, et al.
Published: (2025-02-01) -
Assessing the Impact of Point-based License Systems on Road Safety: A Systematic Review and Meta-analysis
by: Francisco Alonso, et al.
Published: (2025-01-01) -
Risk of stroke associated with proton pump inhibitor use among individuals with and without pre-existing cardiovascular diseases: a systematic review and meta-analysis
by: Muhammed Shabil, et al.
Published: (2025-01-01) -
Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01)